proctosigmoiditis

proctosigmoiditis

 [prok″to-sig″moi-di´tis]
inflammation of the rectum and sigmoid colon.

proc·to·sig·moi·di·tis

(prok'tō-sig'moy-dī'tis),
Inflammation of the sigmoid colon and rectum.
[procto- + sigmoid + G. -itis, inflammation]

proctosigmoiditis

/proc·to·sig·moi·di·tis/ (prok″to-sig″moi-di´tis) inflammation of the rectum and sigmoid colon.

proc·to·sig·moi·di·tis

(prok'tō-sig'moyd-ī'tis)
Inflammation of the sigmoid colon and rectum.
[procto- + sigmoid + G. -itis, inflammation]

proctosigmoiditis

inflammation of the rectum and sigmoid colon.
References in periodicals archive ?
Martin P, Manley PN, Depew WT, et al: Isotretinoin-associated proctosigmoiditis.
Currently we are targeting submission of the NDA for budesonide foam for the treatment of moderate ulcerative proctitis or proctosigmoiditis during the third quarter of 2013.
9) Left-sided UC confers an intermediate degree of risk for neoplasia, whereas proctitis and proctosigmoiditis confer little or none.
ROWASA is indicated for the treatment of active mild to moderate distal ulcerative colitis, proctosigmoiditis, or proctitis.
The Kit contains ROWASA(R) (mesalamine) Rectal Suspension Enema 4g/60mL, a treatment for flare symptoms associated with active mild to moderate left-sided UC, proctosigmoiditis, or ulcerative proctitis, and a personal cleansing wipe for added convenience for those inevitable restroom stops.
Patient enrollment continues in our two identically designed Phase 3, multi-center, double-blind, randomized, placebo-controlled studies evaluating the effectiveness and safety of budesonide rectal foam for the treatment of mild to moderate ulcerative proctitis or proctosigmoiditis.
Hydrocortisone Enema is indicated as adjunctive therapy in the treatment of ulcerative colitis, especially distal forms, including ulcerative proctitis, ulcerative proctosigmoiditis, and left-sided ulcerative colitis.
In addition, patient enrollment is ongoing in our two identically designed Phase 3, multi-center, double-blind, randomized, placebo-controlled studies evaluating the effectiveness and safety of budesonide rectal foam for the treatment of mild to moderate ulcerative proctitis or proctosigmoiditis.
In early October we submitted an IND to the FDA to conduct two identically designed Phase 3, multi-center, double-blind, randomized, placebo-controlled studies evaluating the effectiveness and safety of budesonide rectal foam for the treatment of mild to moderate ulcerative proctitis or proctosigmoiditis.
1 With its sulfite-free preparation, sfRowasa[TM] offers a new treatment option for the treatment of active, mild to moderate distal ulcerative colitis, proctosigmoiditis or proctitis.
NASDAQ:SLXP) today announced that results of a study published in the International Journal of Radiation Oncology-Biology-Physics suggest balsalazide may have potential to prevent or reduce symptoms of radiation-induced proctosigmoiditis (RIPS) in patients undergoing radiation therapy for prostate cancer.